GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Accumulated Depreciation

LakeShore Biopharma Co (LakeShore Biopharma Co) Accumulated Depreciation : $0.00 Mil (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

LakeShore Biopharma Co's quarterly accumulated depreciation increased from Sep. 2022 ($-27.55 Mil) to Mar. 2023 ($-30.29 Mil) but then stayed the same from Mar. 2023 ($-30.29 Mil) to Sep. 2023 ($0.00 Mil).

LakeShore Biopharma Co's annual accumulated depreciation increased from Mar. 2021 ($-24.90 Mil) to Mar. 2022 ($-28.42 Mil) and increased from Mar. 2022 ($-28.42 Mil) to Mar. 2023 ($-30.29 Mil).


LakeShore Biopharma Co Accumulated Depreciation Historical Data

The historical data trend for LakeShore Biopharma Co's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Accumulated Depreciation Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Accumulated Depreciation
-24.90 -28.42 -30.29

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Accumulated Depreciation Get a 7-Day Free Trial - -28.42 -27.55 -30.29 -

LakeShore Biopharma Co Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


LakeShore Biopharma Co Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.